Medicinal chemistry – Page 59
-
FeatureCombating rare diseases
Developing drugs for treating rare diseases isn’t always financially viable. Clare Sansom looks at some recent success stories
-
Opinion'What gets measured gets done'
Measuring R&D productivity is a thorny issue. Dennis Lendrem urges the pharmaceutical industry to learn from its mistakes.
-
OpinionAnalogues by catalogue
Buying in screening compounds directly feels like cutting out the synthetic chemist middleman, says Derek Lowe
-
Business23andMe jumps into drug R&D
Gene profiling firm aims to capitalise on its databank of genetic information to discover new drugs
-
FeatureIt's a bloody business
Determining the role drugs and poisons may have played in death is the responsibility of forensic toxicologists. Nina Notman reports
-
-
-
PodcastBarbituric acid
It may have been largely superceded in the clinic but Phil Robinson discovers there is no rest yet for barbituric acid
-
ResearchProgram ready to weed out tough drug leads
Model could help drug firms avoid synthetically complex dead ends and speed drug discovery
-
ResearchSpicing up MOFs
Framework based on the turmeric pigment curcumin delivers two drugs for the price of one
-
FeatureFrom screen to cell
Nina Notman finds out how liquid crystals are moving into the biotechnology and pharmaceutical toolbox
-
Business
Europe approves stem cell therapy
Treatment for burn-damaged eyes uses patient’s own scaffold-grown cells
-
OpinionA large life, fully lived
Carl Djerassi leaves many legacies besides the contraceptive pill,says Mark Peplow
-
OpinionTantalising technology
Computer-assisted drug design always looks like it’s just about to work, says Derek Lowe, but the reality is complicated
-
-
NewsClinical trials high on list for medical marijuana community
Cannabis compounds hold therapeutic promise but a lack of data and regulatory obstacles are slowing progress
-
ResearchSilver lining for paper Ebola test
Lateral flow test checks for Ebola, yellow fever and dengue in one go
-
OpinionTarget ignorance to tackle resistance
Countries like India are bearing the brunt of antibiotic resistance, and education could be a key tool in tackling its spread
-
NewsUS on track to phase out most long-chain perfluorinated chemicals this year
Discontinuation deadline likely to be met, with measures in place to prevent these chemicals re-entering the US market
-
NewsReview plots path to face down antimicrobial resistance deaths
Billion dollar innovation fund called for to kick-start antimicrobial drug research in the UK